States reach major settlement with family behind OxyContin


This recording was made using enhanced software.

Summary

Purdue Pharma settlement

All 50 U.S. states, Washington, D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

Accountability measures

The settlement requires the Sackler family to give up ownership of Purdue Pharma and permanently bars them from the manufacturing, sale, or marketing of opioids in the United States.

Opioid epidemic impact

From 1999 to 2022, nearly 727,000 people died from opioid overdoses in the United States.


All 50 U.S. states, Washington, D.C., and four U.S. territories have agreed to a $7.4 billion settlement with Purdue Pharma, the company behind OxyContin. The states argued the Sackler family, who own Purdue Pharma, fueled the opioid epidemic by aggressively marketing the addictive drug.

Purdue Pharma lawsuit

The agreement, signed by 55 attorneys general, ends years of legal battles dating back to 2018 when six states first sued Purdue Pharma and the Sackler family. The lawsuits accused the Sacklers of aggressively marketing OxyContin despite its addictive potential.

As part of the new deal, the Sackler family will relinquish ownership of Purdue Pharma. They are also permanently barred from manufacturing, selling or marketing opioids in the United States.

California Attorney General Rob Bonta praised the settlement for providing accountability and help for people with an addiction.

“By holding Purdue Pharma and the Sackler family accountable for their role in fueling the opioid epidemic, we’re bringing much-needed funds for addiction treatment, prevention, and recovery to those impacted by this crisis,” he said in a news release.

The money will go to supporting opioid addiction treatment, prevention, and recovery programs, as well as some victims. Purdue Pharma’s future will be determined by a board of trustees selected by participating states. The company will still be prevented from lobbying or marketing opioids.

This settlement will have to be approved by a federal bankruptcy court. In 2024, the Supreme Court rejected a $6 billion Purdue Pharma bankruptcy deal. It would have protected the Sackler family if Purdue Pharma had filed for bankruptcy.

The court ruled the bankruptcy code does not authorize courts to shield third parties, like the Sacklers, from lawsuits without creditor consent. Purdue then filed the new plan for the $7.4 billion back in March.

“We and our creditors have worked tirelessly in mediation to build consensus and negotiate a settlement that will increase the total value provided to victims and communities, put billions of dollars to work on day one, and serve the public good,” Purdue Board Chairman Steve Miller said following the filing.

If the bankruptcy court approves, local governments across the country will be asked to join the settlement. There will be a hearing for local officials on Wednesday, June 16.

The Sacklers continue to maintain they did nothing wrong.

Opioid epidemic

The opioid epidemic is often said to have come in three waves, beginning in the 1990s with increasing overdose deaths from prescription opioids like OxyContin. The second wave began around 2010, with people struggling to get prescriptions and turning to heroin.

The third wave began around 2013 with significant increases in overdose deaths from synthetic opioids such as fentanyl.

From 1999 to 2022, nearly 727,000 people have died from opioid overdoses.

Tags: ,

Straight Arrow
Fear No Fact.

Don't just take our word for it.


Center-rated reporting

According to media bias experts at AllSides

AllSides Center-rated reporting May 2026

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Why this story matters

A $7.4 billion settlement involving Purdue Pharma and the Sackler family addresses the company’s role in the opioid epidemic and aims to provide funds for addiction treatment and prevention nationwide as well as provide accountability for the opioid epidemic.

Opioid accountability

The settlement requires Purdue Pharma and the Sackler family to relinquish ownership and involvement in opioid production, reflecting efforts to hold those linked to the opioid epidemic responsible, as noted by California Attorney General Rob Bonta and others.

Addiction treatment funding

According to the announcement, the settlement funds are designated to support addiction treatment, prevention, and recovery, aiming to assist victims and communities affected by opioid misuse.

Legal and regulatory outcomes

The agreement follows years of litigation, a Supreme Court decision limiting legal protections for the Sacklers, and ongoing judicial review, highlighting the broader context of legal oversight in addressing public health crises.

Straight Arrow
Fear No Fact.

Don't just take our word for it.


Center-rated reporting

According to media bias experts at AllSides

AllSides Center-rated reporting May 2026

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Timeline

Timeline